{"recordsFiltered":50704,"recordsTotal":50704,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=-status&start=42000","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=-status&start=41400","results":[{"registry_id":"NCT04945642","publication_url":"https://clinicaltrials.gov/study/NCT04945642","title":"Phase 2 Study of High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for Intermediate and High Risk Localized Prostate Adenocarcinoma (HYDRA)","has_exemption":false,"start_date":"2021-08-20","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03597594","publication_url":"https://clinicaltrials.gov/study/NCT03597594","title":"Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)","has_exemption":false,"start_date":"2021-09-02","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05273762","publication_url":"https://clinicaltrials.gov/study/NCT05273762","title":"Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever: Efficacy and Safety","has_exemption":false,"start_date":"2022-01-25","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05026749","publication_url":"https://clinicaltrials.gov/study/NCT05026749","title":"Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children","has_exemption":false,"start_date":"2022-02-27","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04086485","publication_url":"https://clinicaltrials.gov/study/NCT04086485","title":"Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)","has_exemption":false,"start_date":"2022-10-03","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05053971","publication_url":"https://clinicaltrials.gov/study/NCT05053971","title":"Phase Ib/II Study of ZEN003694 and Entinostat in Advanced and Refractory Solid Tumors","has_exemption":false,"start_date":"2022-11-16","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05641753","publication_url":"https://clinicaltrials.gov/study/NCT05641753","title":"CHORD1 - CHOlesterol Lowering and Residual Risk in Diabetes, Type 1","has_exemption":false,"start_date":"2022-12-06","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05442515","publication_url":"https://clinicaltrials.gov/study/NCT05442515","title":"Phase 1/2 Dose Escalation Study of CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies","has_exemption":false,"start_date":"2022-12-28","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05411081","publication_url":"https://clinicaltrials.gov/study/NCT05411081","title":"A Phase II Randomized Trial of Cabozantinib (NSC #761968) With or Without Atezolizumab (NSC #783608) in Patients With Advanced Papillary Renal Cell Carcinoma (PAPMET2)","has_exemption":false,"start_date":"2023-03-24","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05610085","publication_url":"https://clinicaltrials.gov/study/NCT05610085","title":"A Phase IIb Dose Escalation Study of Levetiracetam for the Treatment of Neonatal Seizures","has_exemption":false,"start_date":"2023-03-24","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05570825","publication_url":"https://clinicaltrials.gov/study/NCT05570825","title":"A Phase 2 Trial of SX-682 and Pembrolizumab in Patients With Treatment Naive Stage IV or Recurrent Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2023-04-06","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05419011","publication_url":"https://clinicaltrials.gov/study/NCT05419011","title":"A Phase IIB Clinical Trial of the Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury) Vaccines (TRI-AD5) and IL-15 Superagonist N-803 in Lynch Syndrome","has_exemption":false,"start_date":"2023-05-08","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05846399","publication_url":"https://clinicaltrials.gov/study/NCT05846399","title":"CAT BITE Antibiotic Prophylaxis and Durations for the Hand/Forearm (CATBITE): A Prospective, Randomized, Placebo-controlled, Double-blinded, Clinical Trial","has_exemption":false,"start_date":"2023-09-07","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05891769","publication_url":"https://clinicaltrials.gov/study/NCT05891769","title":"Evaluation of Patients With Suspected Parathyroid Adenoma and Negative or Equivocal 99mTc Sestamibi SPECT/CT Using 18F Fluorocholine PET/CT","has_exemption":false,"start_date":"2023-09-27","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Andrei Iagaru","sponsor_slug":"andrei-iagaru","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05895747","publication_url":"https://clinicaltrials.gov/study/NCT05895747","title":"31P-MRS and Resting State Functional Connectivity Analysis of the Effects of 5-hydroxytryptophan and Creatine for Antidepressant Augmentation in Patients With SSRI/SNRI-resistant Major Depressive Disorder","has_exemption":false,"start_date":"2023-09-28","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06430931","publication_url":"https://clinicaltrials.gov/study/NCT06430931","title":"Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery: a Multicentre, Phase 11-111, Partially Randomised Patient Preference Trial","has_exemption":false,"start_date":"2023-12-06","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Meander Medical Center","sponsor_slug":"meander-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05765500","publication_url":"https://clinicaltrials.gov/study/NCT05765500","title":"RecoverPC: A Phase 2 Study of RElugolix Versus GnRH Agonist Quality of Life (QOL) and Testosterone reCOVERy in Men With Prostate Cancer","has_exemption":false,"start_date":"2024-02-12","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06053580","publication_url":"https://clinicaltrials.gov/study/NCT06053580","title":"Repurposing Valsartan May Protect Against Pulmonary Hypertension","has_exemption":false,"start_date":"2024-02-28","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05966194","publication_url":"https://clinicaltrials.gov/study/NCT05966194","title":"A Randomized Placebo-Controlled Trial of Two Schedules of RRx-001 for the Attenuation of Severe Oral Mucositis in Patients Receiving Concomitant Chemoradiation for the Treatment of Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx","has_exemption":false,"start_date":"2024-04-02","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"EpicentRx, Inc.","sponsor_slug":"epicentrx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06333262","publication_url":"https://clinicaltrials.gov/study/NCT06333262","title":"A Phase 2 Study of Fixed Duration Therapy With Pirtobrutinib and Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia (POP)","has_exemption":false,"start_date":"2024-04-22","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Inhye Ahn","sponsor_slug":"inhye-ahn","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06380517","publication_url":"https://clinicaltrials.gov/study/NCT06380517","title":"A Randomized Trial of Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age","has_exemption":false,"start_date":"2024-07-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Jaeb Center for Health Research","sponsor_slug":"jaeb-center-for-health-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07640425","publication_url":"https://clinicaltrials.gov/study/NCT07640425","title":"A Phase 1/2, Multicenter, Dose Escalating, Dose Expanding, Adaptive Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of Collagenase CNT201 in Adult Participants With Dupuytren's Contracture","has_exemption":false,"start_date":"2024-07-23","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"CONNEXT","sponsor_slug":"connext","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06261814","publication_url":"https://clinicaltrials.gov/study/NCT06261814","title":"2D and 3D Contrast Enhanced Ultrasound of Chemoembolization","has_exemption":false,"start_date":"2024-08-07","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"john eisenbrey","sponsor_slug":"john-eisenbrey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06460298","publication_url":"https://clinicaltrials.gov/study/NCT06460298","title":"Phase I/II Trial Evaluating the Safety and Efficacy of ProAgio, an Anti- αvβ3 Integrin Cytotoxin, in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer","has_exemption":false,"start_date":"2024-08-20","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"ProDa BioTech, LLC","sponsor_slug":"proda-biotech-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05947071","publication_url":"https://clinicaltrials.gov/study/NCT05947071","title":"Comparison of High vs Standard Dose Influenza Vaccines in Pediatric Solid Organ Transplant Recipients","has_exemption":false,"start_date":"2024-09-26","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06579703","publication_url":"https://clinicaltrials.gov/study/NCT06579703","title":"Ketorolac Dosing for Acute Vaso-Occlusive Crisis in Pediatric Patients With Sickle Cell Disease","has_exemption":false,"start_date":"2024-09-30","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Children's Blood and Cancer Center at Dell Children's Medical Center","sponsor_slug":"childrens-blood-and-cancer-center-at-dell-childrens-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06444269","publication_url":"https://clinicaltrials.gov/study/NCT06444269","title":"Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial","has_exemption":false,"start_date":"2024-10-11","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06801717","publication_url":"https://clinicaltrials.gov/study/NCT06801717","title":"Split-Face Comparison of 532nm Potassium Titanyl Phosphate (KTP) Laser Treatment Versus Radiofrequency Microneedling in Combination With 532 KTP Laser for Erythematotelangiectatic or Papulopustular Rosacea","has_exemption":false,"start_date":"2024-11-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06511908","publication_url":"https://clinicaltrials.gov/study/NCT06511908","title":"An Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression","has_exemption":false,"start_date":"2024-11-06","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Mental Health (NIMH)","sponsor_slug":"national-institute-of-mental-health-nimh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06343298","publication_url":"https://clinicaltrials.gov/study/NCT06343298","title":"A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE TITRATION, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SUBCUTANEOUS MANP WHEN ADMINISTERED ONCE DAILY FOR 42 DAYS IN PARTICIPANTS WITH DIFFICULT TO CONTROL HYPERTENSION/RESISTANT HYPERTENSION","has_exemption":false,"start_date":"2024-11-17","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"E-Star BioTech, LLC","sponsor_slug":"e-star-biotech-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04220190","publication_url":"https://clinicaltrials.gov/study/NCT04220190","title":"Phase 2/3 Trial of Autologous Hybrid TREG/Th2 (RAPA-501) T Stem Cell Therapy for Amyotrophic Lateral Sclerosis","has_exemption":false,"start_date":"2025-01-02","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Rapa Therapeutics LLC","sponsor_slug":"rapa-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06803888","publication_url":"https://clinicaltrials.gov/study/NCT06803888","title":"Efficacy and Safety of Bariatric Surgery, Semaglutide Once Weekly, and Tirzepatide Once Weekly in Patients With Obesity","has_exemption":false,"start_date":"2025-01-29","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Ali Aminian","sponsor_slug":"ali-aminian","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06797219","publication_url":"https://clinicaltrials.gov/study/NCT06797219","title":"Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4","has_exemption":false,"start_date":"2025-02-25","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06518057","publication_url":"https://clinicaltrials.gov/study/NCT06518057","title":"A Multi-Center Phase 2 Study of Hippocampal Avoidance in Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumors","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06598423","publication_url":"https://clinicaltrials.gov/study/NCT06598423","title":"Pilot Test of a Novel Wavelength-Based Method to Control Childhood Myopia","has_exemption":false,"start_date":"2025-04-10","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06754501","publication_url":"https://clinicaltrials.gov/study/NCT06754501","title":"A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary","has_exemption":false,"start_date":"2025-04-11","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06902285","publication_url":"https://clinicaltrials.gov/study/NCT06902285","title":"Use of Magnesium-L-Threonate to Improve Subjective Sleep Quality After Total Joint Arthroplasties: Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2025-04-21","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06907446","publication_url":"https://clinicaltrials.gov/study/NCT06907446","title":"Comparison of BARD Max Core 18g Needle With Uro1 SUREcore 18g Needle in Targeted Prostate Biopsies","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07065669","publication_url":"https://clinicaltrials.gov/study/NCT07065669","title":"Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2025-06-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06610448","publication_url":"https://clinicaltrials.gov/study/NCT06610448","title":"Wearable Evaluation of Ambulatory Readings for Blood Pressure","has_exemption":false,"start_date":"2025-06-06","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Stephen Juraschek","sponsor_slug":"stephen-juraschek","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07104500","publication_url":"https://clinicaltrials.gov/study/NCT07104500","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants Without Type 2 Diabetes Who Are Obese, or Overweight With at Least One Weight-related Comorbid Condition","has_exemption":false,"start_date":"2025-06-23","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Viking Therapeutics, Inc.","sponsor_slug":"viking-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07104383","publication_url":"https://clinicaltrials.gov/study/NCT07104383","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants With Type 2 Diabetes Who Are Obese, or Overweight","has_exemption":false,"start_date":"2025-06-23","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Viking Therapeutics, Inc.","sponsor_slug":"viking-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06725017","publication_url":"https://clinicaltrials.gov/study/NCT06725017","title":"A Phase 2, Multi-center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Live SK08 Powder (Bacteroides Fragilis) in Adult Patients with Active Mild to Moderate Ulcerative Colitis","has_exemption":false,"start_date":"2025-07-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Guangzhou Zhiyi Biotechnology Co., Ltd.","sponsor_slug":"guangzhou-zhiyi-biotechnology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616649","publication_url":"https://clinicaltrials.gov/study/NCT06616649","title":"Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.","has_exemption":false,"start_date":"2025-07-14","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06597695","publication_url":"https://clinicaltrials.gov/study/NCT06597695","title":"A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression","has_exemption":false,"start_date":"2025-07-23","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Juliana Zambrano, MD, MPH","sponsor_slug":"juliana-zambrano-md-mph","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07108998","publication_url":"https://clinicaltrials.gov/study/NCT07108998","title":"A Phase 2 Study of Epcoritamab as a Consolidation Therapy for 2nd Generation BTKi +/- Obinutuzumab in CLL/SLL Patients or Variants of This.","has_exemption":false,"start_date":"2025-08-22","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Zulfa Omer","sponsor_slug":"zulfa-omer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06854224","publication_url":"https://clinicaltrials.gov/study/NCT06854224","title":"Orexin Antagonism to Target Mechanisms of Suicide Risk: A Proof-of-Concept Clinical Trial","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Marianne Goodman","sponsor_slug":"marianne-goodman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07121920","publication_url":"https://clinicaltrials.gov/study/NCT07121920","title":"A Prospective Study Evaluating Ex-vivo Confocal Imaging of Fluorescent Tagged Monoclonal Antibodies and Proteomic Profiles of Biopsied Tissue to Predict Therapeutic Response Among Children and Adolescents With Inflammatory Bowel Disease","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Cook Children's Health Care System","sponsor_slug":"cook-childrens-health-care-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07006714","publication_url":"https://clinicaltrials.gov/study/NCT07006714","title":"Preoperative Single High-Dose Vitamin D for Correcting Deficiency in Hip and Knee Arthroplasty Patients-A Prospective Study","has_exemption":false,"start_date":"2025-09-08","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07136779","publication_url":"https://clinicaltrials.gov/study/NCT07136779","title":"PHASE 1/2A OPEN-LABEL CLINICAL TRIAL EVALUATING VBC101, AN EGFR AND CMET TARGETED BI-SPECIFIC ANTIBODY DRUG CONJUGATE, IN PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES","has_exemption":false,"start_date":"2025-09-23","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"VelaVigo Bio Inc","sponsor_slug":"velavigo-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07037836","publication_url":"https://clinicaltrials.gov/study/NCT07037836","title":"Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia","has_exemption":false,"start_date":"2025-09-29","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Bastiaan Driehuys","sponsor_slug":"bastiaan-driehuys","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224997","publication_url":"https://clinicaltrials.gov/study/NCT07224997","title":"Trimethoprim-Sulfamethoxazole (TMP/SMX) Prophylaxis After Acute Kidney Injury to Prevent Post-discharge Infections","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Hospital Civil de Guadalajara","sponsor_slug":"hospital-civil-de-guadalajara","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07410806","publication_url":"https://clinicaltrials.gov/study/NCT07410806","title":"HEALEY ALS Platform Trial - Regimen I NUZ-001","has_exemption":false,"start_date":"2026-02-25","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Merit E. Cudkowicz, MD","sponsor_slug":"merit-e-cudkowicz-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07726173","publication_url":"https://clinicaltrials.gov/study/NCT07726173","title":"Transventricular Off-pump Mitral Valve Repair (TRANSOM)","has_exemption":false,"start_date":"2026-06-08","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07664189","publication_url":"https://clinicaltrials.gov/study/NCT07664189","title":"Left Bundle Branch Pacing + Coronary Sinus Pacing Versus Left Bundle Branch Pacing Alone for Cardiac Resynchronization Therapy in Patients Eligible for CRT-P A Randomized Crossover Pilot Clinical Trial","has_exemption":false,"start_date":"2026-06-09","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Clinica Cardio VID","sponsor_slug":"clinica-cardio-vid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07659366","publication_url":"https://clinicaltrials.gov/study/NCT07659366","title":"HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia: A Prospective, Individually-Randomized, Triple-Blind, Sham-Controlled, Decentralized, Superiority Trial: A Prospective, Decentralized, Individually-randomized, Triple-blind Sham-controlled, Superiority Trial to Evaluate the Safety and Efficacy of HALO Clarity™ Device in Reducing Insomnia Severity.","has_exemption":false,"start_date":"2026-06-22","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Nexalin Technology","sponsor_slug":"nexalin-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07588399","publication_url":"https://clinicaltrials.gov/study/NCT07588399","title":"Randomized Pilot Study to Mechanistically Evaluate Automatic Flow Mode on Impella CP Device During Protected Complex Percutaneous Coronary Intervention","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Rayyan Hemetsberger","sponsor_slug":"rayyan-hemetsberger","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07780981","publication_url":"https://clinicaltrials.gov/study/NCT07780981","title":"Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus Positions","has_exemption":false,"start_date":"2026-07-24","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07610486","publication_url":"https://clinicaltrials.gov/study/NCT07610486","title":"An Open-label, Pharmacokinetic and Safety Trial Optimizing PreTerm Infant Ampicillin Dosing","has_exemption":false,"start_date":"2026-07-28","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07034443","publication_url":"https://clinicaltrials.gov/study/NCT07034443","title":"Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation: A Prospective Pilot Study","has_exemption":false,"start_date":"2026-08-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04383262","publication_url":"https://clinicaltrials.gov/study/NCT04383262","title":"A 12-Week Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy of Oral Fosamprenavir for Laryngopharyngeal Reflux","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07817199","publication_url":"https://clinicaltrials.gov/study/NCT07817199","title":"Time Comparison of Bisacodyl Suppository, Enemeez and Peristeen on Bowel Programs in Patients With Diagnosis of Spinal Cord Injury and Neurogenic Bowel","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Casa Colina Hospital and Centers for Healthcare","sponsor_slug":"casa-colina-hospital-and-centers-for-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07714590","publication_url":"https://clinicaltrials.gov/study/NCT07714590","title":"Effect of Periumbilical Vibration on Pain Perception During Intrauterine Device Insertion: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-10-09","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07600697","publication_url":"https://clinicaltrials.gov/study/NCT07600697","title":"Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery","has_exemption":false,"start_date":"2026-11-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07686328","publication_url":"https://clinicaltrials.gov/study/NCT07686328","title":"A Multicenter Feasibility Study With the VERAFEYE Imaging and Guidance System as Anatomical Navigation System","has_exemption":false,"start_date":"2026-11-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"LUMA Vision Ltd.","sponsor_slug":"luma-vision-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07444827","publication_url":"https://clinicaltrials.gov/study/NCT07444827","title":"Study of Targeted Injection of Nerves to the Knee-A Volunteer Trial Evaluating Nerve to Vastus Medialis","has_exemption":false,"start_date":"2027-01-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07862400","publication_url":"https://clinicaltrials.gov/study/NCT07862400","title":"A Pilot Study on the Efficacy of Oral Low Dose Naltrexone for Vulvodynia","has_exemption":false,"start_date":"2027-01-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04206215","publication_url":"https://clinicaltrials.gov/study/NCT04206215","title":"Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome","has_exemption":false,"start_date":"2021-04-16","completion_date":"2027-07-02","has_results":false,"results_due":false,"sponsor_name":"Spaulding Rehabilitation Hospital","sponsor_slug":"spaulding-rehabilitation-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05831579","publication_url":"https://clinicaltrials.gov/study/NCT05831579","title":"A Phase I Trial of Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy","has_exemption":false,"start_date":"2023-05-12","completion_date":"2027-07-02","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07157787","publication_url":"https://clinicaltrials.gov/study/NCT07157787","title":"A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1920 in Adult Participants With PMN (Primary Membranous Nephropathy) Who Are at a High Risk for Disease Progression","has_exemption":false,"start_date":"2025-09-19","completion_date":"2027-07-02","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07756138","publication_url":"https://clinicaltrials.gov/study/NCT07756138","title":"A Pilot Trial to Evaluate the Efficacy and Safety of Filsuvez in the Treatment of Moderate-to-Severe Epidermolysis Bullosa Simplex","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-07-02","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06002906","publication_url":"https://clinicaltrials.gov/study/NCT06002906","title":"The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery","has_exemption":false,"start_date":"2023-01-25","completion_date":"2027-07-03","has_results":false,"results_due":false,"sponsor_name":"University Health Network, Toronto","sponsor_slug":"university-health-network-toronto","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06211036","publication_url":"https://clinicaltrials.gov/study/NCT06211036","title":"A Phase 3, Open-label, Multicenter, Randomized Study of Tarlatamab in Combination With Durvalumab vs Durvalumab Alone in Subjects With Extensive-Stage Small-Cell Lung Cancer Following Platinum, Etoposide and Durvalumab (DeLLphi-305)","has_exemption":false,"start_date":"2024-06-05","completion_date":"2027-07-05","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630091","publication_url":"https://clinicaltrials.gov/study/NCT06630091","title":"A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study","has_exemption":false,"start_date":"2025-02-21","completion_date":"2027-07-05","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04077099","publication_url":"https://clinicaltrials.gov/study/NCT04077099","title":"A Phase 1/2 Study of REGN5093 in Patients With MET-Altered Advanced Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2020-01-07","completion_date":"2027-07-06","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05897320","publication_url":"https://clinicaltrials.gov/study/NCT05897320","title":"Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine","has_exemption":false,"start_date":"2023-06-08","completion_date":"2027-07-06","has_results":false,"results_due":false,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03580083","publication_url":"https://clinicaltrials.gov/study/NCT03580083","title":"A Phase I/II Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Intracisternal RGX-111 Gene Therapy in Participants With Mucopolysaccharidosis Type I","has_exemption":false,"start_date":"2019-04-03","completion_date":"2027-07-07","has_results":false,"results_due":false,"sponsor_name":"Regenxbio Inc.","sponsor_slug":"regenxbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06907875","publication_url":"https://clinicaltrials.gov/study/NCT06907875","title":"A Phase 1/2 Open-label Dose-escalation Study to Evaluate the Safety, Tolerability, and Biological Activity of EPI-321, an AAVrh74-delivered Epigenetic Editing Therapy in Adult FSHD Patients","has_exemption":false,"start_date":"2025-05-08","completion_date":"2027-07-07","has_results":false,"results_due":false,"sponsor_name":"Epicrispr Biotechnologies, Inc.","sponsor_slug":"epicrispr-biotechnologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07158164","publication_url":"https://clinicaltrials.gov/study/NCT07158164","title":"DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment","has_exemption":false,"start_date":"2025-08-27","completion_date":"2027-07-07","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07497880","publication_url":"https://clinicaltrials.gov/study/NCT07497880","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity","has_exemption":false,"start_date":"2026-04-06","completion_date":"2027-07-07","has_results":false,"results_due":false,"sponsor_name":"Kailera","sponsor_slug":"kailera","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07610837","publication_url":"https://clinicaltrials.gov/study/NCT07610837","title":"A Phase IIa, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD2389 in Adult Participants With Steatotic Liver Disease and Advanced Fibrosis (BRAVO)","has_exemption":false,"start_date":"2026-05-07","completion_date":"2027-07-07","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05517304","publication_url":"https://clinicaltrials.gov/study/NCT05517304","title":"Transcutaneous Vagal Nerve Stimulation in Veterans With Posttraumatic Stress Disorder","has_exemption":false,"start_date":"2022-10-01","completion_date":"2027-07-08","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04833140","publication_url":"https://clinicaltrials.gov/study/NCT04833140","title":"Estrogen Administration for the Treatment of NASH in Postmenopausal Women","has_exemption":false,"start_date":"2021-12-02","completion_date":"2027-07-09","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06095128","publication_url":"https://clinicaltrials.gov/study/NCT06095128","title":"An Open-Label, Phase 4, Single-Arm, Multicenter Study to Evaluate the Induction of Response and Remission of Vedolizumab Dual Targeted Therapy With Tofacitinib in Adult Patients With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2024-06-12","completion_date":"2027-07-09","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06290141","publication_url":"https://clinicaltrials.gov/study/NCT06290141","title":"A Phase 3, Randomized, Double-blind, Study Evaluating Efficacy and Safety of Riliprubart Versus Intravenous Immunoglobulin (IVIg) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy","has_exemption":false,"start_date":"2024-08-21","completion_date":"2027-07-09","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07851246","publication_url":"https://clinicaltrials.gov/study/NCT07851246","title":"A Phase 3 Randomized, Observer-Blind, Controlled Study to Evaluate the Immunogenicity, Reactogenicity and Safety of an mRNA-based Seasonal Influenza Vaccine, in Adults 18-64 Years of Age","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-07-09","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06312176","publication_url":"https://clinicaltrials.gov/study/NCT06312176","title":"An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-04-14","completion_date":"2027-07-11","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06594627","publication_url":"https://clinicaltrials.gov/study/NCT06594627","title":"Smart Pillows for Enhancing Sleep Quality_Pilot Study","has_exemption":false,"start_date":"2024-11-18","completion_date":"2027-07-11","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03582774","publication_url":"https://clinicaltrials.gov/study/NCT03582774","title":"Phase III Randomized Multicenter Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]","has_exemption":false,"start_date":"2018-07-12","completion_date":"2027-07-12","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05441280","publication_url":"https://clinicaltrials.gov/study/NCT05441280","title":"Pimavanserin for Insomnia in Veterans With Post-traumatic Stress Disorder","has_exemption":false,"start_date":"2023-12-28","completion_date":"2027-07-12","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07843550","publication_url":"https://clinicaltrials.gov/study/NCT07843550","title":"A Phase 1/2 Trial Of Larotrectinib And Pembrolizumab In Patients With Solid Tumors Previously Treated With Immune Checkpoint Inhibitor Monotherapy","has_exemption":false,"start_date":"2027-03-01","completion_date":"2027-07-13","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06205706","publication_url":"https://clinicaltrials.gov/study/NCT06205706","title":"Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First-in-Human, Consecutive-Cohort, Clinical Trial of BI-1910, a Monoclonal Antibody to Tumor Necrosis Factor Receptor 2 (TNFR2), as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-12-04","completion_date":"2027-07-14","has_results":false,"results_due":false,"sponsor_name":"BioInvent International AB","sponsor_slug":"bioinvent-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06079879","publication_url":"https://clinicaltrials.gov/study/NCT06079879","title":"A Phase 3, Randomized, Open-label, Active-Comparator-Controlled Clinical Study to Evaluate the Safety and Efficacy of Bomedemstat (MK-3543/IMG-7289) Versus Best Available Therapy (BAT) in Participants With Essential Thrombocythemia Who Have an Inadequate Response to or Are Intolerant of Hydroxyurea","has_exemption":false,"start_date":"2023-12-31","completion_date":"2027-07-14","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06470022","publication_url":"https://clinicaltrials.gov/study/NCT06470022","title":"Randomized Comparison of Evolut FX Versus Sapien 3 Ultra Resilia. The Compare-TAVI 2 Trial","has_exemption":false,"start_date":"2024-08-09","completion_date":"2027-07-14","has_results":false,"results_due":false,"sponsor_name":"Christian Juhl Terkelsen","sponsor_slug":"christian-juhl-terkelsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06847867","publication_url":"https://clinicaltrials.gov/study/NCT06847867","title":"A Phase 2, Randomized, Open-label, Study of Momelotinib in Participants With Anemia Due to Low-risk Myelodysplastic Syndrome","has_exemption":false,"start_date":"2025-06-05","completion_date":"2027-07-14","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03516708","publication_url":"https://clinicaltrials.gov/study/NCT03516708","title":"Phase I/II Study of Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer","has_exemption":false,"start_date":"2020-01-06","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05189457","publication_url":"https://clinicaltrials.gov/study/NCT05189457","title":"A Phase IIA Study of Sequential (\"First Strike, Second Strike\") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for High Risk Metastatic Castration Sensitive Prostate Cancer","has_exemption":false,"start_date":"2022-01-25","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05111574","publication_url":"https://clinicaltrials.gov/study/NCT05111574","title":"A Randomized Phase II Trial of Adjuvant Nivolumab With or Without Cabozantinib in Patients With Resected Mucosal Melanoma","has_exemption":false,"start_date":"2022-08-11","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05057494","publication_url":"https://clinicaltrials.gov/study/NCT05057494","title":"A Phase III Prospective, Multicenter, Randomized, Open-Label Trial of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","has_exemption":false,"start_date":"2022-09-12","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04757116","publication_url":"https://clinicaltrials.gov/study/NCT04757116","title":"A Post-Market, Prospective, Randomized, Controlled, Multicenter International Study to Assess the Safety of the Temporarily Implanted Nitinol Device (iTind) Compared to the UroLift® System in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)","has_exemption":false,"start_date":"2022-09-26","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Olympus Corporation of the Americas","sponsor_slug":"olympus-corporation-of-the-americas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05892744","publication_url":"https://clinicaltrials.gov/study/NCT05892744","title":"Establishing Multimodal Brain Biomarkers Using Data-driven Analytics for Treatment Selection in Depression","has_exemption":false,"start_date":"2023-09-30","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06940674","publication_url":"https://clinicaltrials.gov/study/NCT06940674","title":"Adjunctive Cannabidiol for Recovery From Opioid Study (ACROS)","has_exemption":false,"start_date":"2025-06-13","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06830863","publication_url":"https://clinicaltrials.gov/study/NCT06830863","title":"A Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety, Bioavailability, and Effect of Topically Administered ATR04-484 for Moderate to Severe EGFRi-Associated Dermal Toxicity","has_exemption":false,"start_date":"2025-08-25","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Azitra Inc.","sponsor_slug":"azitra-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325292","publication_url":"https://clinicaltrials.gov/study/NCT07325292","title":"A Randomized, Phase 3, Open-label Study to Investigate Pharmacokinetics, Safety, and Efficacy of Subcutaneous Compared to Intravenous Frexalimab in Adult Participants With Multiple Sclerosis","has_exemption":false,"start_date":"2026-01-14","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07573059","publication_url":"https://clinicaltrials.gov/study/NCT07573059","title":"A Multicenter, Prospective Study Assessing the Safety of Loargys Arginine Test System for Determining Arginine in Loargys-treated Patients","has_exemption":false,"start_date":"2026-04-17","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Immedica Pharma US Inc","sponsor_slug":"immedica-pharma-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282639","publication_url":"https://clinicaltrials.gov/study/NCT07282639","title":"Development and Evaluation of App-Based Certified Diabetes Education (AB-CDE) Therapy for People Living With T1D Using MDI","has_exemption":false,"start_date":"2026-07-08","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07702513","publication_url":"https://clinicaltrials.gov/study/NCT07702513","title":"A Pilot Randomized Waitlist-Controlled Study of Home-Based Rhythmic Auditory Stimulation to Evaluate Mobility, Balance, and Patient-Reported Outcomes After Traumatic Brain Injury","has_exemption":false,"start_date":"2026-07-15","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Craig Hospital","sponsor_slug":"craig-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07723664","publication_url":"https://clinicaltrials.gov/study/NCT07723664","title":"Evaluation of SofWave Sofware-Guided Energy Delivery for Lower Face and Neck Rejuvenation","has_exemption":false,"start_date":"2026-07-20","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Sofwave Medical LTD","sponsor_slug":"sofwave-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07588672","publication_url":"https://clinicaltrials.gov/study/NCT07588672","title":"Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Polyrizon Ltd.","sponsor_slug":"polyrizon-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03460067","publication_url":"https://clinicaltrials.gov/study/NCT03460067","title":"Selective Use of Observation After Lumpectomy and Sentinel Lymph Node Biopsy in Her-2 Positive Patients With Pathologic Complete Response to Neoadjuvant Chemotherapy","has_exemption":false,"start_date":"2018-02-23","completion_date":"2027-07-16","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05347212","publication_url":"https://clinicaltrials.gov/study/NCT05347212","title":"Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla","has_exemption":false,"start_date":"2022-09-22","completion_date":"2027-07-16","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05664737","publication_url":"https://clinicaltrials.gov/study/NCT05664737","title":"A Phase 2, Study for the Treatment of Anemia With Alpha (α)-Thalassemia to Determine the Efficacy and Safety of Luspatercept (BMS-986346/ACE-536) in Adults and Evaluate the Safety and Pharmacokinetics in Adolescents","has_exemption":false,"start_date":"2022-12-09","completion_date":"2027-07-16","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07047118","publication_url":"https://clinicaltrials.gov/study/NCT07047118","title":"A Phase II, Randomized, Open-label, Multi-center Study of JSB462 (Luxdegalutamide) in Combination With Lutetium (177Lu) Vipivotide Tetraxetan in Adult Male Patients With PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2025-07-03","completion_date":"2027-07-16","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02396459","publication_url":"https://clinicaltrials.gov/study/NCT02396459","title":"Tiratricol Treatment of Children With Monocarboxylate Transporter 8 Deficiency: Triac Trial II","has_exemption":false,"start_date":"2020-12-07","completion_date":"2027-07-18","has_results":false,"results_due":false,"sponsor_name":"Rare Thyroid Therapeutics International AB","sponsor_slug":"rare-thyroid-therapeutics-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06321601","publication_url":"https://clinicaltrials.gov/study/NCT06321601","title":"A Phase 3, Open-label, Uncontrolled Single-arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Avacopan in Combination With a Rituximab or a Cyclophosphamide-containing Regimen in Children From 6 Years to < 18 Years of Age With Active ANCA-associated Vasculitis (AAV)","has_exemption":false,"start_date":"2024-10-22","completion_date":"2027-07-18","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07187778","publication_url":"https://clinicaltrials.gov/study/NCT07187778","title":"Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-07-19","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04108156","publication_url":"https://clinicaltrials.gov/study/NCT04108156","title":"A Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active-comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic Macular Edema (Pagoda)","has_exemption":true,"start_date":"2019-09-30","completion_date":"2027-07-20","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06362252","publication_url":"https://clinicaltrials.gov/study/NCT06362252","title":"A Phase 1b/2, Multicenter, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody-Drug Conjugate (ADC), in Combination With Atezolizumab With or Without Carboplatin as First-line Induction or Maintenance, in Subjects With Extensive-stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung03)","has_exemption":false,"start_date":"2024-07-22","completion_date":"2027-07-20","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07846631","publication_url":"https://clinicaltrials.gov/study/NCT07846631","title":"Perioperative Photobiomodulation With the ELIXIR MD System in Facial Plastic Surgery: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-10-12","completion_date":"2027-07-20","has_results":false,"results_due":false,"sponsor_name":"Elixir MD Inc","sponsor_slug":"elixir-md-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03708900","publication_url":"https://clinicaltrials.gov/study/NCT03708900","title":"A Phase II, Multicenter, Open-label, Non-comparative Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Osilodrostat in Children and Adolescent Patients With Cushing's Syndrome","has_exemption":false,"start_date":"2021-04-28","completion_date":"2027-07-21","has_results":false,"results_due":false,"sponsor_name":"RECORDATI GROUP","sponsor_slug":"recordati-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05555485","publication_url":"https://clinicaltrials.gov/study/NCT05555485","title":"Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain","has_exemption":false,"start_date":"2023-05-24","completion_date":"2027-07-21","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05531786","publication_url":"https://clinicaltrials.gov/study/NCT05531786","title":"Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","has_exemption":false,"start_date":"2023-03-06","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06472206","publication_url":"https://clinicaltrials.gov/study/NCT06472206","title":"Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)","has_exemption":false,"start_date":"2024-09-23","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06632600","publication_url":"https://clinicaltrials.gov/study/NCT06632600","title":"A Randomized, Participant- and Investigator-blinded, Controlled, Parallel Group Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LXE408 in Participants With Chronic Chagas Disease Without Severe Organ Dysfunction.","has_exemption":false,"start_date":"2025-04-28","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07044297","publication_url":"https://clinicaltrials.gov/study/NCT07044297","title":"A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis","has_exemption":false,"start_date":"2025-07-31","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07062965","publication_url":"https://clinicaltrials.gov/study/NCT07062965","title":"An Interventional, Open-Label, Randomized, Multicenter, Phase 3 Study of PF-07248144 Plus Fulvestrant Compared to Investigator's Choice of Therapy in Adult Participants With Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Whose Disease Progressed After Prior CDK4/6 Inhibitor-based Therapy","has_exemption":false,"start_date":"2025-08-05","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161037","publication_url":"https://clinicaltrials.gov/study/NCT07161037","title":"A Phase 2a, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VX-407 in Subjects With Autosomal Dominant Polycystic Kidney Disease Who Have a Subset of PKD1 Gene Variants","has_exemption":false,"start_date":"2025-11-19","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06975865","publication_url":"https://clinicaltrials.gov/study/NCT06975865","title":"A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Flexible-adaptive, Group Sequential Study to Evaluate the Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease","has_exemption":false,"start_date":"2025-08-12","completion_date":"2027-07-23","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05837767","publication_url":"https://clinicaltrials.gov/study/NCT05837767","title":"A Pilot Study of Spatially Fractionated Radiation Therapy in Patients With Extra-Cranial Soft Tissue Metastases","has_exemption":false,"start_date":"2023-07-24","completion_date":"2027-07-24","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07044310","publication_url":"https://clinicaltrials.gov/study/NCT07044310","title":"Phase 2 Trial of 5-Strain Probiotic Formulation in Hormone Receptor-Positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss","has_exemption":false,"start_date":"2025-07-25","completion_date":"2027-07-25","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07677683","publication_url":"https://clinicaltrials.gov/study/NCT07677683","title":"A Phase 2 Study of STP705 Injection for Submental Fat Reduction","has_exemption":false,"start_date":"2026-07-28","completion_date":"2027-07-25","has_results":false,"results_due":false,"sponsor_name":"Sirnaomics","sponsor_slug":"sirnaomics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06155643","publication_url":"https://clinicaltrials.gov/study/NCT06155643","title":"EKO SENSORA: Detecting Clinically Significant Murmurs","has_exemption":false,"start_date":"2023-10-26","completion_date":"2027-07-26","has_results":false,"results_due":false,"sponsor_name":"Corewell Health South","sponsor_slug":"corewell-health-south","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00840047","publication_url":"https://clinicaltrials.gov/study/NCT00840047","title":"Methionine PET/CT Studies In Patients With Cancer","has_exemption":false,"start_date":"2009-07-20","completion_date":"2027-07-27","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05718869","publication_url":"https://clinicaltrials.gov/study/NCT05718869","title":"A Phase 2 Study With a Safety Lead-In of the Anti-CD19 Antibody Tafasitamab With the BTK Inhibitor Zanubrutinib in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - TaZa CLL Study","has_exemption":false,"start_date":"2023-05-18","completion_date":"2027-07-27","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07007793","publication_url":"https://clinicaltrials.gov/study/NCT07007793","title":"Parent Study: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Baxdrostat in Adult Participants With Primary Aldosteronism Sub-study: A Substudy to Describe PA Disease Characteristics After Completion of the BaxPA Main Study","has_exemption":false,"start_date":"2025-08-07","completion_date":"2027-07-27","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06103864","publication_url":"https://clinicaltrials.gov/study/NCT06103864","title":"A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)","has_exemption":false,"start_date":"2023-11-23","completion_date":"2027-07-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06098144","publication_url":"https://clinicaltrials.gov/study/NCT06098144","title":"Expanding the Role of the Safety Manager to Implement a Workplace Smoking Cessation Program in the Construction Sector","has_exemption":false,"start_date":"2024-04-10","completion_date":"2027-07-28","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07467993","publication_url":"https://clinicaltrials.gov/study/NCT07467993","title":"A Phase 2a, Randomized, Participant- and Investigator- Blinded, Parallel-group, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With DSM-5 Schizophrenia (STAR-1)","has_exemption":false,"start_date":"2026-03-16","completion_date":"2027-07-29","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02703220","publication_url":"https://clinicaltrials.gov/study/NCT02703220","title":"Pathophysiology-Guided Therapy for Sleep Apnea in the Elderly","has_exemption":false,"start_date":"2015-07-03","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03040973","publication_url":"https://clinicaltrials.gov/study/NCT03040973","title":"An Open-label, Multi-center, Global, Rollover Study for Patients Who Have Previously Been Treated With Capmatinib (INC280) as Monotherapy or in Combination in a Novartis Sponsored Trial.","has_exemption":false,"start_date":"2017-07-04","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03535298","publication_url":"https://clinicaltrials.gov/study/NCT03535298","title":"Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis","has_exemption":false,"start_date":"2019-01-03","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04524871","publication_url":"https://clinicaltrials.gov/study/NCT04524871","title":"A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)","has_exemption":false,"start_date":"2020-11-01","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04806516","publication_url":"https://clinicaltrials.gov/study/NCT04806516","title":"Development of Adaptive Deep Brain Stimulation (aDBS) for the Treatment of Intractable Obsessive-Compulsive Disorder (OCD) Phase II Using Summit RC+S System With ECoG Paddles","has_exemption":false,"start_date":"2021-07-01","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07280377","publication_url":"https://clinicaltrials.gov/study/NCT07280377","title":"A Phase 1 / 2 Multiple-indication Biomarker, Safety, and Efficacy Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab","has_exemption":false,"start_date":"2021-10-27","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Oncolytics Biotech","sponsor_slug":"oncolytics-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04853251","publication_url":"https://clinicaltrials.gov/study/NCT04853251","title":"A Phase IV, Multicenter, Open-label Study to Assess Corneal Endothelial Cells in Patients With Neovascular Age-related Macular Degeneration Treated With the Port Delivery System With Ranibizumab (PDS)","has_exemption":false,"start_date":"2021-12-14","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05090891","publication_url":"https://clinicaltrials.gov/study/NCT05090891","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva","has_exemption":false,"start_date":"2022-05-05","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04011748","publication_url":"https://clinicaltrials.gov/study/NCT04011748","title":"Clinical Treatment of Alopecia Areata With Stem Cell Educator Therapy","has_exemption":false,"start_date":"2022-09-20","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Throne Biotechnologies Inc.","sponsor_slug":"throne-biotechnologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05455320","publication_url":"https://clinicaltrials.gov/study/NCT05455320","title":"A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone (DPd), in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received at Least 1 Prior Line of Therapy","has_exemption":false,"start_date":"2022-10-13","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672524","publication_url":"https://clinicaltrials.gov/study/NCT05672524","title":"A Phase II Study of Induction Tucatinib and Trastuzumab With Total Neoadjuvant Therapy for Locally Advanced HER2-amplified Rectal Adenocarcinoma","has_exemption":false,"start_date":"2022-12-30","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05470491","publication_url":"https://clinicaltrials.gov/study/NCT05470491","title":"A Phase I/II Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Transplantation Followed by GVHD Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies in People Living With HIV (PLWH)","has_exemption":false,"start_date":"2023-01-26","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05282550","publication_url":"https://clinicaltrials.gov/study/NCT05282550","title":"RCT Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone (REST)","has_exemption":false,"start_date":"2023-02-02","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05557877","publication_url":"https://clinicaltrials.gov/study/NCT05557877","title":"Targeted Prevention of Postpartum-Related Breast Cancer","has_exemption":false,"start_date":"2023-03-09","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05794906","publication_url":"https://clinicaltrials.gov/study/NCT05794906","title":"A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Darolutamide Plus Androgen Deprivation Therapy (ADT) Compared With Placebo Plus ADT in Patients With High-risk Biochemical Recurrence (BCR) of Prostate Cancer","has_exemption":false,"start_date":"2023-04-03","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05507541","publication_url":"https://clinicaltrials.gov/study/NCT05507541","title":"Phase 2 Study With Safety run-in of PD-1 Inhibitor and IgG4 SIRPα-Fc Fusion Protein (TTI-622) in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)","has_exemption":false,"start_date":"2023-04-19","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06072183","publication_url":"https://clinicaltrials.gov/study/NCT06072183","title":"A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBO-CONTROLLED MULTI-CENTER STUDY WITH A DOUBLE-BLIND 52-WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UP/DOSE DOWN TITRATION INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO","has_exemption":false,"start_date":"2023-11-08","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05904028","publication_url":"https://clinicaltrials.gov/study/NCT05904028","title":"Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD","has_exemption":false,"start_date":"2023-11-09","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Jaeb Center for Health Research","sponsor_slug":"jaeb-center-for-health-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05941806","publication_url":"https://clinicaltrials.gov/study/NCT05941806","title":"Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection: a Double-blind Placebo-controlled Clinical Trial","has_exemption":false,"start_date":"2023-11-10","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"CHU de Quebec-Universite Laval","sponsor_slug":"chu-de-quebec-universite-laval","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06439771","publication_url":"https://clinicaltrials.gov/study/NCT06439771","title":"A Multicenter, Open-Label, Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With Locally Advanced or Metastatic Breast Cancer With TNBC, HR-Positive, HER2-Zero-expression or HER2-Low-expression","has_exemption":false,"start_date":"2024-04-23","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"MediLink Therapeutics (Suzhou) Co., Ltd.","sponsor_slug":"medilink-therapeutics-suzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06096779","publication_url":"https://clinicaltrials.gov/study/NCT06096779","title":"A Phase II, Open-label, Multi-cohort, Multicenter Study in Patients With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis","has_exemption":false,"start_date":"2024-07-15","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06448754","publication_url":"https://clinicaltrials.gov/study/NCT06448754","title":"A Phase II, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of Volrustomig Priming Regimens in Combination With Other Anticancer Agents in Participants With Solid Tumors (eVOLVE-01)","has_exemption":false,"start_date":"2024-08-27","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06470048","publication_url":"https://clinicaltrials.gov/study/NCT06470048","title":"A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis","has_exemption":false,"start_date":"2024-10-09","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06635824","publication_url":"https://clinicaltrials.gov/study/NCT06635824","title":"A Prospective, Open-Label, Randomized, Phase 3 Trial of Acasunlimab (GEN1046) in Combination With Pembrolizumab Versus Docetaxel in Subjects With PD-L1 Positive Metastatic Non-Small Cell Lung Cancer After Treatment With a PD-1/PD-L1 Inhibitor and Platinum-Containing Chemotherapy (ABBIL1TY NSCLC-06)","has_exemption":false,"start_date":"2024-11-25","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06636656","publication_url":"https://clinicaltrials.gov/study/NCT06636656","title":"Phase IIa, Sequential Cohort, Open-label, Multi-center Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Induction and Subcutaneous Maintenance Treatment With BI 3032950 in Patients With Moderate to Severe Ulcerative Colitis","has_exemption":false,"start_date":"2024-12-11","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05727761","publication_url":"https://clinicaltrials.gov/study/NCT05727761","title":"Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia","has_exemption":false,"start_date":"2025-01-01","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06132685","publication_url":"https://clinicaltrials.gov/study/NCT06132685","title":"Post-Operative Dosing of Steroids Post Craniotomy for Brain Tumor (PODS)","has_exemption":false,"start_date":"2025-01-09","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06466161","publication_url":"https://clinicaltrials.gov/study/NCT06466161","title":"Evaluation of the Agreement Between Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients","has_exemption":false,"start_date":"2025-04-29","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06918808","publication_url":"https://clinicaltrials.gov/study/NCT06918808","title":"A Phase 2a Study of Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product (DB-3Q) in Patients With Perianal Fistulizing Crohn's Disease","has_exemption":false,"start_date":"2025-05-19","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Direct Biologics, LLC","sponsor_slug":"direct-biologics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06566664","publication_url":"https://clinicaltrials.gov/study/NCT06566664","title":"Peripheral Neurostimulation for Nerve Block Placement","has_exemption":false,"start_date":"2025-07-23","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06772233","publication_url":"https://clinicaltrials.gov/study/NCT06772233","title":"A Phase II, Open-label, Multicenter, Randomized Controlled Clinical Trial Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment.","has_exemption":false,"start_date":"2025-07-30","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Peking University","sponsor_slug":"peking-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07010016","publication_url":"https://clinicaltrials.gov/study/NCT07010016","title":"Early Feasibility Study of Focused Ultrasound (FUS) Neuromodulation in Patients With Opioid Use Disorder and/or Other Substance Use Disorders","has_exemption":false,"start_date":"2025-08-07","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Manish Ranjan","sponsor_slug":"manish-ranjan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221539","publication_url":"https://clinicaltrials.gov/study/NCT07221539","title":"Restoration of Consciousness With Ultrasonic Deep Brain Stimulation During Anesthetic Sedation","has_exemption":false,"start_date":"2025-10-24","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07704658","publication_url":"https://clinicaltrials.gov/study/NCT07704658","title":"A Multi-center, Open-label, Drug-drug Interaction Study to Evaluate the Effect of Pralsetinib (Gavreto) on the Pharmacokinetics of CYP3A4, CYP2C8, and CYP2C9 Substrates, and Hormones Estradiol/Norethisterone Acetate in Patients With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2026-03-04","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Rigel Pharmaceuticals","sponsor_slug":"rigel-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07608588","publication_url":"https://clinicaltrials.gov/study/NCT07608588","title":"Recovery From Post-Stroke Aphasia With rTMS Targeting the Anterior Temporal Lobe: Interhemispheric Activation Changes and Lesion-Connectome-Based Predictive Outcomes","has_exemption":false,"start_date":"2026-05-15","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"University of South Carolina","sponsor_slug":"university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07046819","publication_url":"https://clinicaltrials.gov/study/NCT07046819","title":"A Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Phase 2 Study of Efficacy and Safety of Tirzepatide in Individuals With Alcohol Use Disorder and Metabolic Alcohol-associated Liver Disease","has_exemption":false,"start_date":"2026-06-11","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","sponsor_slug":"national-institute-on-alcohol-abuse-and-alcoholism-niaaa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07619131","publication_url":"https://clinicaltrials.gov/study/NCT07619131","title":"A Phase III Randomised, Double-Blind, Factorial Design Study to Assess the Effect of Fixed Dose Combination Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on Low-Density Lipoprotein Cholesterol in Lipid-Lowering Treatment-Naïve Patients","has_exemption":false,"start_date":"2026-08-12","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07706712","publication_url":"https://clinicaltrials.gov/study/NCT07706712","title":"Evaluation of the DuoVT PFA System for Ventricular Tachycardia","has_exemption":false,"start_date":"2026-09-29","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07792330","publication_url":"https://clinicaltrials.gov/study/NCT07792330","title":"Asthma Lung Sounds With Wearable Stethoscope","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Los Angeles","sponsor_slug":"childrens-hospital-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06406465","publication_url":"https://clinicaltrials.gov/study/NCT06406465","title":"A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity","has_exemption":false,"start_date":"2026-10-25","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00715611","publication_url":"https://clinicaltrials.gov/study/NCT00715611","title":"Phase II Toxicity Study of Pleurectomy/Decortication, (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma","has_exemption":false,"start_date":"2008-10-11","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00909909","publication_url":"https://clinicaltrials.gov/study/NCT00909909","title":"Safety and Feasibility of Accelerated, Hypofractionated Radiotherapy in Women With Breast Cancer: A Phase II Trial","has_exemption":false,"start_date":"2009-05-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01530373","publication_url":"https://clinicaltrials.gov/study/NCT01530373","title":"A Phase II Randomized Study of Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients Receiving Adjuvant Hormonal Therapy","has_exemption":false,"start_date":"2012-02-29","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01639508","publication_url":"https://clinicaltrials.gov/study/NCT01639508","title":"A Phase II Study of Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity","has_exemption":false,"start_date":"2012-07-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02225600","publication_url":"https://clinicaltrials.gov/study/NCT02225600","title":"The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults: A Pilot Behavioral Study","has_exemption":false,"start_date":"2014-08-26","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02262832","publication_url":"https://clinicaltrials.gov/study/NCT02262832","title":"Compassionate Use of Metreleptin in Previously-Treated Patients With Generalized Lipodystrophy","has_exemption":false,"start_date":"2014-10-09","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02262806","publication_url":"https://clinicaltrials.gov/study/NCT02262806","title":"Compassionate Use of Metreleptin in Previously-Treated Patients With Partial Lipodystrophy","has_exemption":false,"start_date":"2014-10-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02232191","publication_url":"https://clinicaltrials.gov/study/NCT02232191","title":"Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients","has_exemption":false,"start_date":"2014-12-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02502162","publication_url":"https://clinicaltrials.gov/study/NCT02502162","title":"Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome","has_exemption":false,"start_date":"2015-06-30","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02479698","publication_url":"https://clinicaltrials.gov/study/NCT02479698","title":"Phase II Study Assessing the Effect of BK Specific CTL Lines Generated by Ex Vivo Expansion in Patients With BK Virus Infection and JC Virus Infection","has_exemption":false,"start_date":"2015-07-23","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02502786","publication_url":"https://clinicaltrials.gov/study/NCT02502786","title":"A Phase II Study of Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma","has_exemption":false,"start_date":"2015-07-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02698254","publication_url":"https://clinicaltrials.gov/study/NCT02698254","title":"Pilot Trial of Dose-Volume Constraints for Reirradiation of Recurrent Brain Tumors","has_exemption":false,"start_date":"2016-07-20","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02846987","publication_url":"https://clinicaltrials.gov/study/NCT02846987","title":"Phase 2 Study of Abemaciclib (LY2835219) in Dedifferentiated Liposarcoma","has_exemption":false,"start_date":"2016-07-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03006068","publication_url":"https://clinicaltrials.gov/study/NCT03006068","title":"A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects With Ulcerative Colitis","has_exemption":false,"start_date":"2017-01-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03085147","publication_url":"https://clinicaltrials.gov/study/NCT03085147","title":"A Phase I/II Study of the Fluorescent PARP1 Binding Imaging Agent PARPi-FL in Patients With Oral Squamous Cell Carcinomas","has_exemption":false,"start_date":"2017-03-15","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03067051","publication_url":"https://clinicaltrials.gov/study/NCT03067051","title":"Open-label Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System (Interstitial Multiple Diode Lasers and IDOSE® Software) and Verteporfin for Injection (VFI) for the Treatment of Recurrent Prostate Cancer","has_exemption":false,"start_date":"2017-03-21","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"SpectraCure AB","sponsor_slug":"spectracure-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02845323","publication_url":"https://clinicaltrials.gov/study/NCT02845323","title":"Randomized Phase II Study of Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder","has_exemption":false,"start_date":"2017-05-16","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03220646","publication_url":"https://clinicaltrials.gov/study/NCT03220646","title":"A Phase 2 Study of Abemaciclib in Patients With Recurrent Primary Brain Tumors","has_exemption":false,"start_date":"2017-07-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03181100","publication_url":"https://clinicaltrials.gov/study/NCT03181100","title":"Atezolizumab Combinations With Chemotherapy for Anaplastic and Poorly Differentiated Thyroid Carcinomas","has_exemption":false,"start_date":"2017-07-27","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03214510","publication_url":"https://clinicaltrials.gov/study/NCT03214510","title":"Randomized, Unblinded, Phase III Trial of Thoracic Epidural Analgesia Versus Four-Quadrant Transversus Abdominus Plane Block in Oncologic Open-Incision Liver Surgery","has_exemption":false,"start_date":"2017-10-04","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03304080","publication_url":"https://clinicaltrials.gov/study/NCT03304080","title":"A Multicenter, Phase I/II Trial of Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast Cancer","has_exemption":false,"start_date":"2017-12-20","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03328078","publication_url":"https://clinicaltrials.gov/study/NCT03328078","title":"An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma","has_exemption":false,"start_date":"2017-12-28","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Curis, Inc.","sponsor_slug":"curis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03467516","publication_url":"https://clinicaltrials.gov/study/NCT03467516","title":"A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Uveal Melanoma","has_exemption":false,"start_date":"2018-05-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Udai Kammula","sponsor_slug":"udai-kammula","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03541902","publication_url":"https://clinicaltrials.gov/study/NCT03541902","title":"Cabosun Ii: Cabozantinib Versus Sunitinib for Metastatic Variant Histology Renal Cell Carcinoma","has_exemption":false,"start_date":"2018-05-15","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03556332","publication_url":"https://clinicaltrials.gov/study/NCT03556332","title":"Phase 2 Trial of Intensive Chemo-immunotherapy With Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Relapsed/Refractory Myeloma in the Context of Salvage Autologous Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2018-07-02","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587844","publication_url":"https://clinicaltrials.gov/study/NCT03587844","title":"Optimizing Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome, and Lymphomatoid Papulosis","has_exemption":false,"start_date":"2018-07-03","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03604302","publication_url":"https://clinicaltrials.gov/study/NCT03604302","title":"Identification of Essential Areas of the Brain in Pre-Operative Brain Tumor Patients Using BOLD fMRI and Independent Physiological Parameters","has_exemption":false,"start_date":"2018-08-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03623958","publication_url":"https://clinicaltrials.gov/study/NCT03623958","title":"Image Guided VATS Resection vs. VATS Resection of Lung Lesions","has_exemption":false,"start_date":"2018-09-11","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06443359","publication_url":"https://clinicaltrials.gov/study/NCT06443359","title":"Hypofractionated Regional Nodal Irradiation in Breast Cancer","has_exemption":false,"start_date":"2018-11-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03546582","publication_url":"https://clinicaltrials.gov/study/NCT03546582","title":"KEYSTROKE: A Randomized Phase II Study of Pembrolizumab (KEYTRUDA®) Plus Stereotactic Re-irradiation Versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma","has_exemption":false,"start_date":"2018-11-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"RTOG Foundation, Inc.","sponsor_slug":"rtog-foundation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03521830","publication_url":"https://clinicaltrials.gov/study/NCT03521830","title":"Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma","has_exemption":false,"start_date":"2018-11-27","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03406611","publication_url":"https://clinicaltrials.gov/study/NCT03406611","title":"A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Effects on Clinical Outcomes of Pegtibatinase (TVT-058) Administered Subcutaneously in Subjects With Cystathionine Beta Synthase-Deficient Homocystinuria (COMPOSE)","has_exemption":false,"start_date":"2019-01-22","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Travere Therapeutics, Inc.","sponsor_slug":"travere-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03810196","publication_url":"https://clinicaltrials.gov/study/NCT03810196","title":"CD45RA Depleted Peripheral Stem Cell Addback for Patients at Risk for Viral or Fungal Infections Post TCRαβ/CD19 Depleted Hematopoietic Stem Cell Transplant","has_exemption":false,"start_date":"2019-03-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03708224","publication_url":"https://clinicaltrials.gov/study/NCT03708224","title":"A Phase II Study of Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck","has_exemption":false,"start_date":"2019-03-08","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Alain Algazi","sponsor_slug":"alain-algazi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03977233","publication_url":"https://clinicaltrials.gov/study/NCT03977233","title":"Impact of Tumor and Stromal Subtypes on Efficacy of Neoadjuvant FOLFIRINOX in Subjects With Non-Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2019-06-12","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04022213","publication_url":"https://clinicaltrials.gov/study/NCT04022213","title":"Phase II Combination of 131I-Omburtamab Radioimmunotherapy and External Beam Radiotherapy for Desmoplastic Small Round Cell Tumor","has_exemption":false,"start_date":"2019-07-15","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03999710","publication_url":"https://clinicaltrials.gov/study/NCT03999710","title":"Durvalumab With Thoracic Radiation Therapy Without Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (DART)","has_exemption":false,"start_date":"2019-07-19","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04082533","publication_url":"https://clinicaltrials.gov/study/NCT04082533","title":"Effect of Intravenous Hydrocortisone on Range of Motion After Total Knee Arthroplasty: A Randomized Placebo-Controlled Trial With Nested Case-Control Study","has_exemption":false,"start_date":"2019-07-24","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04065776","publication_url":"https://clinicaltrials.gov/study/NCT04065776","title":"A Phase II Study of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma","has_exemption":false,"start_date":"2019-08-28","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04151082","publication_url":"https://clinicaltrials.gov/study/NCT04151082","title":"Stop LCNP: High Dose Steroid Therapy for Late Radiation-Associated Lower Cranial Neuropathy: A Phase I/II Dose Finding Trial and Data Registry","has_exemption":false,"start_date":"2019-10-16","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04045470","publication_url":"https://clinicaltrials.gov/study/NCT04045470","title":"A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma","has_exemption":false,"start_date":"2019-12-11","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04073563","publication_url":"https://clinicaltrials.gov/study/NCT04073563","title":"Prospective, Randomized, Controlled, Blinded Pivotal Study In Subjects Undergoing A Transforaminal Lumbar Interbody Fusion (TLIF) At One Or Two Levels Using Infuse™ Bone Graft With an Intervertebral Body Fusion Device and Posterior Supplemental Fixation For The Treatment Of Symptomatic Degenerative Disease Of The Lumbosacral Spine","has_exemption":false,"start_date":"2019-12-19","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Spinal and Biologics","sponsor_slug":"medtronic-spinal-and-biologics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04022239","publication_url":"https://clinicaltrials.gov/study/NCT04022239","title":"Post-Transplant Bendamustine (PT-BEN) for GVHD Prophylaxis","has_exemption":false,"start_date":"2020-03-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01187368","publication_url":"https://clinicaltrials.gov/study/NCT01187368","title":"Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System: the COMPETENCE Trial","has_exemption":false,"start_date":"2020-03-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Evaheart, Inc.","sponsor_slug":"evaheart-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04297683","publication_url":"https://clinicaltrials.gov/study/NCT04297683","title":"HEALEY ALS Platform Trial","has_exemption":false,"start_date":"2020-06-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Merit E. Cudkowicz, MD","sponsor_slug":"merit-e-cudkowicz-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02314988","publication_url":"https://clinicaltrials.gov/study/NCT02314988","title":"Topical Application of Tranexamic Acid (CYKLOKAPRON®) to Reduce Blood Loss During Spine Surgery","has_exemption":false,"start_date":"2020-06-15","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04469075","publication_url":"https://clinicaltrials.gov/study/NCT04469075","title":"The PROTECT Study: A Phase II, Open-Label Trial of PROphylactic Skin Toxicity ThErapy With Clindamycin and Triamcinolone in Glioblastoma Patients Treated With Tumor Treating Fields","has_exemption":false,"start_date":"2020-07-09","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04333576","publication_url":"https://clinicaltrials.gov/study/NCT04333576","title":"A Phase 3b Study to Evaluate the Safety and Efficacy of Elagolix in Combination With Combined Oral Contraceptives in Premenopausal Women With Documented Endometriosis and Associated Moderate to Severe Pain","has_exemption":false,"start_date":"2020-08-10","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04363164","publication_url":"https://clinicaltrials.gov/study/NCT04363164","title":"A Randomized Phase II Study Comparing Sequential High Dose Testosterone and Enzalutamide to Enzalutamide Alone in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer","has_exemption":false,"start_date":"2020-08-19","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04401748","publication_url":"https://clinicaltrials.gov/study/NCT04401748","title":"A Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Azacitidine in Patients Newly Diagnosed With Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)","has_exemption":false,"start_date":"2020-09-10","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05585788","publication_url":"https://clinicaltrials.gov/study/NCT05585788","title":"Efficacy of a Pill-Dispensing System to Increase Disposal of Unused Opioids and to Reduce Refills After Cancer-Related Surgery","has_exemption":false,"start_date":"2020-10-05","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04447768","publication_url":"https://clinicaltrials.gov/study/NCT04447768","title":"A Phase II: Venetoclax-Based Therapy for the Treatment of Fit Patients With Chronic Lymphocytic Leukemia (CLL) in the Front-Line Setting","has_exemption":false,"start_date":"2020-12-03","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04697784","publication_url":"https://clinicaltrials.gov/study/NCT04697784","title":"Post-Approval Study of the TREO Abdominal Stent-Graft System (P190015) in Patients With Infrarenal Abdominal Aortic and Aorto-iliac Aneurysms","has_exemption":false,"start_date":"2021-01-20","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Bolton Medical","sponsor_slug":"bolton-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04760899","publication_url":"https://clinicaltrials.gov/study/NCT04760899","title":"Bilateral Cerebellar Transcranial Direct Current Stimulation (tDCS) for the Treatment of Sports-Related Post-Concussion Syndrome (SRPCS)","has_exemption":false,"start_date":"2021-03-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04639050","publication_url":"https://clinicaltrials.gov/study/NCT04639050","title":"A Phase Ib/IIa, Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Patients With Prodromal or Mild to Moderate Alzheimer's Disease","has_exemption":false,"start_date":"2021-03-15","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04595747","publication_url":"https://clinicaltrials.gov/study/NCT04595747","title":"Phase 2 Study of Rogaratinib (BAY 1163877) in the Treatment of Patients With Sarcoma Harboring Alterations in Fibroblast Growth Factor Receptor (FGFR) 1-4 and SDH-Deficient Gastrointestinal Stromal Tumor (GIST)","has_exemption":false,"start_date":"2021-05-03","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04586959","publication_url":"https://clinicaltrials.gov/study/NCT04586959","title":"Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer","has_exemption":false,"start_date":"2021-05-21","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Anthony Costales, MD","sponsor_slug":"anthony-costales-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04765137","publication_url":"https://clinicaltrials.gov/study/NCT04765137","title":"Targeting Cerebrovascular Reactivity for Precision Medicine: Pilot Trial of Atorvastatin","has_exemption":false,"start_date":"2021-05-21","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04606914","publication_url":"https://clinicaltrials.gov/study/NCT04606914","title":"Single-Arm Phase II Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer Who Are Folate Receptor α Positive","has_exemption":false,"start_date":"2021-05-27","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04841148","publication_url":"https://clinicaltrials.gov/study/NCT04841148","title":"A Phase II Trial of Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)","has_exemption":false,"start_date":"2021-06-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03701581","publication_url":"https://clinicaltrials.gov/study/NCT03701581","title":"4-aminopyridine Treatment for Nerve Injury Resulting From Radical Retro-Pubic Prostatectomy","has_exemption":false,"start_date":"2021-06-05","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"John Elfar","sponsor_slug":"john-elfar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04957719","publication_url":"https://clinicaltrials.gov/study/NCT04957719","title":"Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Self-administered Subcutaneous Selatogrel for Prevention of All-cause Death and Treatment of Acute Myocardial Infarction in Subjects With a Recent History of Acute Myocardial Infarction","has_exemption":false,"start_date":"2021-08-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Viatris Innovation GmbH","sponsor_slug":"viatris-innovation-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05024695","publication_url":"https://clinicaltrials.gov/study/NCT05024695","title":"A Prospective, Multicenter Masked Clinical Trial to Evaluate the Safety and Effectiveness of the MINIject CS627 Implant in Subjects With Open Angle Glaucoma","has_exemption":false,"start_date":"2021-08-19","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"iSTAR Medical","sponsor_slug":"istar-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03776162","publication_url":"https://clinicaltrials.gov/study/NCT03776162","title":"BEAR - MOON: A Two Arm Non-Inferiority Randomized Clinical Trial Comparing ACL Repair With BEAR Device vs. Autograft Patellar Tendon ACL Reconstruction","has_exemption":false,"start_date":"2021-08-30","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04991454","publication_url":"https://clinicaltrials.gov/study/NCT04991454","title":"Xenon MRI in Pulmonary Hypertension","has_exemption":true,"start_date":"2021-09-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Bastiaan Driehuys","sponsor_slug":"bastiaan-driehuys","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03921060","publication_url":"https://clinicaltrials.gov/study/NCT03921060","title":"Markers of Osteoporosis in Cystic Fibrosis","has_exemption":false,"start_date":"2021-09-02","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04976335","publication_url":"https://clinicaltrials.gov/study/NCT04976335","title":"Quantitative and Clinical Assessment of Flexor Tendon Gliding Following Application of a Bioresorbable Hydrogel: A Prospective, Randomized Study in Patients Undergoing Distal Radius Fracture Repair.","has_exemption":false,"start_date":"2021-09-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04594798","publication_url":"https://clinicaltrials.gov/study/NCT04594798","title":"Phase 2 Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL","has_exemption":false,"start_date":"2021-09-20","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04960618","publication_url":"https://clinicaltrials.gov/study/NCT04960618","title":"Pembrolizumab in Combination With Gemcitabine for Previously Treated Mycosis Fungoides and Sézary Syndrome: Efficacy and Characterization of Immune Response","has_exemption":false,"start_date":"2021-10-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05003310","publication_url":"https://clinicaltrials.gov/study/NCT05003310","title":"Multipart Exploratory Study to Evaluate Splenic Nerve Stimulation in Patients With Rheumatoid Arthritis","has_exemption":false,"start_date":"2021-10-19","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Galvani Bioelectronics","sponsor_slug":"galvani-bioelectronics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05108974","publication_url":"https://clinicaltrials.gov/study/NCT05108974","title":"Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study","has_exemption":false,"start_date":"2021-10-22","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Jeff Wozniak","sponsor_slug":"jeff-wozniak","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04923542","publication_url":"https://clinicaltrials.gov/study/NCT04923542","title":"Phase I/II Study of Stereotactic Radiation and Abemaciclib With or Without Imlunestrant in the Management of Hormone Receptor Positive HER2 Negative Breast Cancer Brain Metastases (STRONG Trial)","has_exemption":false,"start_date":"2021-11-30","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04207437","publication_url":"https://clinicaltrials.gov/study/NCT04207437","title":"Daily Hand-Held Vibration Therapy for the Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN): A Pilot Study","has_exemption":false,"start_date":"2021-12-06","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05102019","publication_url":"https://clinicaltrials.gov/study/NCT05102019","title":"Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II","has_exemption":false,"start_date":"2022-01-04","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Shockwave Medical, Inc.","sponsor_slug":"shockwave-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05011188","publication_url":"https://clinicaltrials.gov/study/NCT05011188","title":"A Phase 1b/2 Study of FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2022-01-19","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Rahul Aggarwal","sponsor_slug":"rahul-aggarwal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05207670","publication_url":"https://clinicaltrials.gov/study/NCT05207670","title":"An Open-Label, Multicenter, Phase II Trial Evaluating the Safety, Efficacy, and Pharmacokinetics of Subcutaneous Mosunetuzumab Monotherapy in Patients With Select B-Cell Malignancies","has_exemption":false,"start_date":"2022-02-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05167786","publication_url":"https://clinicaltrials.gov/study/NCT05167786","title":"Locomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke","has_exemption":false,"start_date":"2022-03-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Shirley Ryan AbilityLab","sponsor_slug":"shirley-ryan-abilitylab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05028062","publication_url":"https://clinicaltrials.gov/study/NCT05028062","title":"Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation","has_exemption":false,"start_date":"2022-03-07","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04644211","publication_url":"https://clinicaltrials.gov/study/NCT04644211","title":"A Phase 2 Study Of Ruxolitinib In Low-Risk Essential Thrombocythemia And Polycythemia Vera With Significant Symptom Burden","has_exemption":false,"start_date":"2022-03-21","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05401929","publication_url":"https://clinicaltrials.gov/study/NCT05401929","title":"Imaging the Effects of Intermittent Thetaburst Stimulation on Cannabis Self-Administration in Heavy Cannabis Users","has_exemption":false,"start_date":"2022-06-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05301101","publication_url":"https://clinicaltrials.gov/study/NCT05301101","title":"High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis (REDIRICT)","has_exemption":false,"start_date":"2022-06-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05209438","publication_url":"https://clinicaltrials.gov/study/NCT05209438","title":"Cereset Research for Caregivers: A Randomized, Controlled Trial","has_exemption":false,"start_date":"2022-06-16","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05172960","publication_url":"https://clinicaltrials.gov/study/NCT05172960","title":"Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve","has_exemption":false,"start_date":"2022-06-20","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05460533","publication_url":"https://clinicaltrials.gov/study/NCT05460533","title":"Phase II Open Label Multicenter Study of Early REinFusion of Tisagenlecleucel to Promote DUrable B-CEll ApLasia in Pediatric and Young Adult Patients With Relapsed/Refractory CD19-Positive B-Cell Acute Lymphoblastic Leukemia (REFUEL)","has_exemption":false,"start_date":"2022-07-12","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05434598","publication_url":"https://clinicaltrials.gov/study/NCT05434598","title":"A Prospective Study of Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS","has_exemption":false,"start_date":"2022-07-27","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05440760","publication_url":"https://clinicaltrials.gov/study/NCT05440760","title":"Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy","has_exemption":false,"start_date":"2022-08-08","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05600738","publication_url":"https://clinicaltrials.gov/study/NCT05600738","title":"Network Effects of Therapeutic Deep Brain Stimulation","has_exemption":false,"start_date":"2022-08-26","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03887273","publication_url":"https://clinicaltrials.gov/study/NCT03887273","title":"A Phase 1/2a Open-Label Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Transverse Myelitis (TM)","has_exemption":false,"start_date":"2022-09-20","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Q Therapeutics, Inc.","sponsor_slug":"q-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05524935","publication_url":"https://clinicaltrials.gov/study/NCT05524935","title":"A Phase II Trial of Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma","has_exemption":false,"start_date":"2022-10-11","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05053867","publication_url":"https://clinicaltrials.gov/study/NCT05053867","title":"A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients","has_exemption":false,"start_date":"2022-10-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05460793","publication_url":"https://clinicaltrials.gov/study/NCT05460793","title":"Dutch ICH Surgery Trial; Minimally Invasive Endoscopy-guided Surgery for Spontaneous Supratentorial Intracerebral Hemorrhage","has_exemption":false,"start_date":"2022-11-03","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Radboud University Medical Center","sponsor_slug":"radboud-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05215327","publication_url":"https://clinicaltrials.gov/study/NCT05215327","title":"Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients","has_exemption":false,"start_date":"2022-11-08","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05438199","publication_url":"https://clinicaltrials.gov/study/NCT05438199","title":"Prototyping a Device for Automating Stool and Urine Output Tracking","has_exemption":false,"start_date":"2022-11-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05425459","publication_url":"https://clinicaltrials.gov/study/NCT05425459","title":"Re-Evaluation of the Corvia Atrial Shunt Device in a Precision Medicine Trial to Determine Efficacy in Mildly Reduced or Preserved Ejection Fraction (EF) Heart Failure (Protocol #2201)","has_exemption":false,"start_date":"2022-11-17","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Corvia Medical","sponsor_slug":"corvia-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05579366","publication_url":"https://clinicaltrials.gov/study/NCT05579366","title":"Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors","has_exemption":false,"start_date":"2022-12-07","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05292339","publication_url":"https://clinicaltrials.gov/study/NCT05292339","title":"Single Blind RCT to Evaluate the Effect of Ketorolac in Upper Extremity Tendinopathy and Arthropathy","has_exemption":false,"start_date":"2023-01-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05587751","publication_url":"https://clinicaltrials.gov/study/NCT05587751","title":"Evaluating the Impact of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse (TGD) Patients","has_exemption":false,"start_date":"2023-02-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04711109","publication_url":"https://clinicaltrials.gov/study/NCT04711109","title":"BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation","has_exemption":false,"start_date":"2023-02-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05735080","publication_url":"https://clinicaltrials.gov/study/NCT05735080","title":"A Phase 1/2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of INX-315 in Patients With Advanced Cancer","has_exemption":false,"start_date":"2023-03-28","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Incyclix Bio","sponsor_slug":"incyclix-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05346809","publication_url":"https://clinicaltrials.gov/study/NCT05346809","title":"Randomized Phase 2 Trial of Isatuximab During Autologous Stem Cell Collection and Transplantation Period in Patients With Multiple Myeloma, Relapsed Hodgkin's and Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2023-03-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Divaya Bhutani","sponsor_slug":"divaya-bhutani","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05592015","publication_url":"https://clinicaltrials.gov/study/NCT05592015","title":"A Phase II Study Evaluating the Efficacy of Ruxolitinib in Patients With T-Cell Large Granular Lymphocytic Leukemia (T-LGLL)","has_exemption":false,"start_date":"2023-05-03","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Jonathan Brammer","sponsor_slug":"jonathan-brammer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05809531","publication_url":"https://clinicaltrials.gov/study/NCT05809531","title":"An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis","has_exemption":false,"start_date":"2023-05-29","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Apellis Pharmaceuticals, Inc.","sponsor_slug":"apellis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05636124","publication_url":"https://clinicaltrials.gov/study/NCT05636124","title":"Cost Effectiveness, Safety, and Efficacy of the Kaneka iED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms","has_exemption":false,"start_date":"2023-06-02","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05821309","publication_url":"https://clinicaltrials.gov/study/NCT05821309","title":"Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen","has_exemption":false,"start_date":"2023-06-08","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05776524","publication_url":"https://clinicaltrials.gov/study/NCT05776524","title":"A Phase 2 Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2023-06-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"THERABIONIC INC.","sponsor_slug":"therabionic-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04808505","publication_url":"https://clinicaltrials.gov/study/NCT04808505","title":"An Open-label Study to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Cipaglucosidase Alfa/Miglustat in Both ERT-experienced and ERT-naïve Pediatric Subjects With Infantile-onset Pompe Disease Aged 0 to < 18 Years","has_exemption":false,"start_date":"2023-07-18","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Amicus Therapeutics","sponsor_slug":"amicus-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05116384","publication_url":"https://clinicaltrials.gov/study/NCT05116384","title":"A Trial to Evaluate Renal Artery Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation","has_exemption":false,"start_date":"2023-07-30","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05797246","publication_url":"https://clinicaltrials.gov/study/NCT05797246","title":"A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)","has_exemption":false,"start_date":"2023-08-02","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06501859","publication_url":"https://clinicaltrials.gov/study/NCT06501859","title":"Rehabilitation With the Shoulder Pacemaker After Reverse Shoulder Arthroplasty","has_exemption":false,"start_date":"2023-08-02","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05975580","publication_url":"https://clinicaltrials.gov/study/NCT05975580","title":"Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery","has_exemption":false,"start_date":"2023-08-29","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05724173","publication_url":"https://clinicaltrials.gov/study/NCT05724173","title":"Single Neuron Population Dynamics in Human Speech Motor Cortex for a Speech Prosthesis","has_exemption":false,"start_date":"2023-10-18","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Leigh R. Hochberg, MD, PhD.","sponsor_slug":"leigh-r-hochberg-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05970497","publication_url":"https://clinicaltrials.gov/study/NCT05970497","title":"A Phase 1/2, Open-Label, Multi-Center, Dose Escalation and Expansion Study of KB707 in Subjects With Locally Advanced or Metastatic Solid Tumor Malignancies","has_exemption":false,"start_date":"2023-10-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Krystal Biotech, Inc.","sponsor_slug":"krystal-biotech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04778046","publication_url":"https://clinicaltrials.gov/study/NCT04778046","title":"Defining a Noninvasive Signature for Pulmonary Vascular Remodeling in Group 3 PH","has_exemption":false,"start_date":"2023-11-08","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Bastiaan Driehuys","sponsor_slug":"bastiaan-driehuys","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06095583","publication_url":"https://clinicaltrials.gov/study/NCT06095583","title":"A Randomized, Double-Blind, Placebo-Controlled, Multi-Regional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy","has_exemption":false,"start_date":"2023-11-15","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","sponsor_slug":"shanghai-junshi-bioscience-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05917522","publication_url":"https://clinicaltrials.gov/study/NCT05917522","title":"Assessment of Biomarker-Guided Calcineurin Inhibitor (CNI) Substitution In Kidney Transplantation (RTB-015)","has_exemption":false,"start_date":"2023-12-07","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05959733","publication_url":"https://clinicaltrials.gov/study/NCT05959733","title":"Maximal Repair Versus Bridging Reconstruction with BioBrace® for the Treatment of Chronic, Massive Rotator Cuff Tears: Clinical, Radiographic, and In-vivo Biomechanical Analysis","has_exemption":false,"start_date":"2023-12-07","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Nova Scotia Health Authority","sponsor_slug":"nova-scotia-health-authority","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05879913","publication_url":"https://clinicaltrials.gov/study/NCT05879913","title":"Personalized Medical Treatment of Coronary Atherosclerosis in Prostate Cancer Patients Guided by Plaque Assessment With Quantitative Coronary CT Angiography (CCTA)","has_exemption":false,"start_date":"2023-12-15","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05559671","publication_url":"https://clinicaltrials.gov/study/NCT05559671","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Non-inferiority Crossover Study Evaluating the Safety and Immunogenicity of the Herpes Zoster Subunit Vaccine in Patients With Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2023-12-21","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06005818","publication_url":"https://clinicaltrials.gov/study/NCT06005818","title":"Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)","has_exemption":false,"start_date":"2024-01-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06082518","publication_url":"https://clinicaltrials.gov/study/NCT06082518","title":"Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments (PCS-HBOT Study)","has_exemption":false,"start_date":"2024-01-02","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Sunnybrook Health Sciences Centre","sponsor_slug":"sunnybrook-health-sciences-centre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05967182","publication_url":"https://clinicaltrials.gov/study/NCT05967182","title":"A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma","has_exemption":false,"start_date":"2024-01-16","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05702749","publication_url":"https://clinicaltrials.gov/study/NCT05702749","title":"Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas","has_exemption":false,"start_date":"2024-01-22","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null}]}